CFO’s Quiet Buy‑Back Signals Confidence in Harmony Biosciences as Insider Activity Spurs Optimism
Harmony Biosciences CFO adds shares, signaling insider confidence in its neurologic pipeline and potential stock rebound.
- HARMONY BIOSCIENCES HOLDINGS
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read